Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Abstract Chemotherapeutics are widely used in cancer treatments, but their toxicity, bioavailability and solubility present challenges
In its lawsuit, the OFA said that the FDAs decision to end the shortage was a reckless and arbitrary move and could deprive patients of a vital treatment for type 2 diabetes and obesity. In an interview with BioSpace last month, David Rosen, partner at Foley & Lardner, said that the lawsuit is a precedent in this area. Prior to the OFA suit, no one has ever challenged the FDAs decision to remove a therapy from the drug shortage list. The OFA case is still ongoing, with the next court update due on Thursday
While both can support weight loss, they work in different ways
10.1111/j.1476-5381.2010.00669.x Br
Collado, M
Structural Engineering Modern pharmaceutical peptides are often intentionally engineered for enhanced stability
